This image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Thursday, July 8, 2021, U.S. health regulators approved new prescribing instructions for the controversial Alzheimer’s drug that are likely to limit use of the expensive therapy, which has faced an intense public backlash. Credit: Biogen via AP, File
A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use.
The Food and Drug Administration said the change is intended to address confusion among physicians and patients about who should get the…
Efesbet, kullanıcı dostu bir platform sunarak oyuncuların rahatça bahis yapmalarını ve kazanç elde etmelerini sağlar. Kazandıran içeriklerle dolu platformlar, oyun severlerin ilk tercihleri arasında...
Bahis severler, en iyi platformlar sayesinde hızlı ödemeler ve cazip bonuslarla daha verimli bir oyun deneyimi yaşar. Kullanıcılar, platformların sunduğu deneme bonuslarıyla oyun dünyasına...
